KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Aurinia Pharmaceuticals (AUPH) Shares Repurchased (2024 - 2025)

Aurinia Pharmaceuticals' Shares Repurchased history spans 2 years, with the latest figure at $8.7 million for Q3 2025.

  • For Q3 2025, Shares Repurchased changed N/A year-over-year to $8.7 million; the TTM value through Dec 2025 reached $98.2 million, up 143.93%, while the annual FY2025 figure was $98.2 million, 143.93% up from the prior year.
  • Shares Repurchased reached $8.7 million in Q3 2025 per AUPH's latest filing, down from $42.6 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $46.9 million in Q1 2025 to a low of $6.1 million in Q2 2024.